Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4132-4144

  Nicolson, Sarah C ^a   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; KARYOPHERIN BETA; SMALL INTERFERING RNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; GENE SILENCING; GENETIC ANALYSIS; IN VITRO STUDY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEROTYPE; SIGNAL TRANSDUCTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; DEPENDOVIRUS; GENETIC ENGINEERING; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LAMINS; NUCLEAR PORE; TRANSDUCTION, GENETIC;

EID: 84897016759     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02660-13     Document Type: Article

References (91)

1. Atchison RW, Casto BC, Hammon WM. 1965. Adenovirus-associated defective virus particles. Science 149:754-756.
2. Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ. 2010. AAV's anatomy: roadmap for optimizing vectors for translational success. Curr. Gene Ther. 10:319-340. http://dx.doi.org/10.2174/156652310793180706.
3. Asokan A, Schaffer DV, Samulski RJ. 2012. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20:699-708. http://dx.doi.org/10.1038/mt.2011.287.
4. Ding W, Yan Z, Zak R, Saavedra M, Rodman DM, Engelhardt JF. 2003. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77:7361-7366. http://dx.doi.org/10.1128/JVI.77.13.7361-7366.2003.
5. Hauck B, Zhao W, High K, Xiao W. 2004. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J. Virol. 78:13678-13686. http://dx.doi.org/10.1128/JVI.78.24.13678-13686.2004.
6. Sanlioglu S, Benson PK, Yang J, Atkinson EM, Reynolds T, Engelhardt JF. 2000. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74:9184-9196. http://dx.doi.org/10.1128/JVI.74.19.9184-9196.2000.
7. Hansen J, Qing K, Srivastava A. 2001. Infection of purified nuclei by deno-associated virus 2. Mol. Ther. 4:289-296. http://dx.doi.org/10.1006/mthe.2001.0457.
8. Johnson FB, Ozer HL, Hoggan MD. 1971. Structural proteins of adenovirus-associated virus type 3. J. Virol. 8:860-863.
9. Salo RJ, Mayor HD. 1977. Structural polypeptides of parvoviruses. Virology 78:340-345.
10. Summerford C, Samulski RJ. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
11. Summerford C, Bartlett JS, Samulski RJ. 1999. αVβ5 integrin: a coreceptor for adeno-associated virus type 2 infection. Nat. Med. 5:78-82.
12. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A. 1999. Humanfibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
13. Duan D, Li Q, Kao AW, Yue Y, Pessin JE, Engelhardt JF. 1999. Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73:10371-10376.
14. Nonnenmacher M, Weber T. 2011. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 10:563-576. http://dx.doi.org/10.1016/j.chom.2011.10.014.
15. Bantel-Schaal U, Hub B, Kartenbeck J. 2002. Endocytosis of adenoassociated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J. Virol. 76:2340-2349. http://dx.doi.org/10.1128/JVI.76.5.2340-2349.2002.
16. Bartlett JS, Wilcher R, Samulski RJ. 2000. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74: 2777-2785. http://dx.doi.org/10.1128/JVI.74.6.2777-2785.2000.
17. Douar AM, Poulard K, Stockholm D, Danos O. 2001. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75:1824-1833. http://dx.doi.org/10.1128/JVI.75.4.1824-1833.2001.
18. Xiao PJ, Samulski RJ. 2012. Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network. J. Virol. 86:10462-10473. http://dx.doi.org/10.1128/JVI.00935-12.
19. Ding W, Zhang LN, Yeaman C, Engelhardt JF. 2006. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion. Mol. Ther. 13:671-682. http://dx.doi.org/10.1016/j.ymthe.2005.12.002.
20. Pajusola K, Gruchala M, Joch H, Luscher TF, Yla-Herttuala S, Bueler H. 2002. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J. Virol. 76:11530-11540. http://dx.doi.org/10.1128/JVI.76.22.11530-11540.2002.
21. Bleker S, Sonntag F, Kleinschmidt JA. 2005. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. J. Virol. 79:2528-2540. http://dx.doi.org/10.1128/JVI.79.4.2528-2540.2005.
22. Kronenberg S, Bottcher B, von der Lieth CW, Bleker S, Kleinschmidt JA. 2005. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J. Virol. 79:5296-5303. http://dx.doi.org/10.1128/JVI.79.9.5296-5303.2005.
23. Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA. 2006. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 80:11040-11054. http://dx.doi.org/10.1128/JVI.01056-06.
24. Girod A, Wobus CE, Zadori Z, Ried M, Leike K, Tijssen P, Kleinschmidt JA, Hallek M. 2002. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol. 83:973-978. http://vir.sgmjournals.org/content/83/5/973.long.
25. Grieger JC, Snowdy S, Samulski RJ. 2006. Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J. Virol. 80:5199-5210. http://dx.doi.org/10.1128/JVI.02723-05.
26. Johnson JS, Li C, DiPrimio N, Weinberg MS, McCown TJ, Samulski RJ. 2010. Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cellspecific transduction. J. Virol. 84:8888-8902. http://dx.doi.org/10.1128/JVI.00687-10.
27. Johnson JS, Samulski RJ. 2009. Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J. Virol. 83:2632-2644. http://dx.doi.org/10.1128/JVI.02309-08.
28. Xiao PJ, Li C, Neumann A, Samulski RJ. 2012. Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues. Mol. Ther. 20:317-328. http://dx.doi.org/10.1038/mt.2011.250.
29. Li C, He Y, Nicolson S, Hirsch M, Weinberg MS, Zhang P, Kafri T, Samulski RJ. 2013. Adeno-associated virus capsid antigen presentation is dependent on endosomal escape. J. Clin. Invest. 123:1390-1401. http://dx.doi.org/10.1172/JCI66611.
30. Sorokin AV, Kim ER, Ovchinnikov LP. 2007. Nucleocytoplasmic transport of proteins. Biochemistry (Mosc.) 72:1439-1457. http://dx.doi.org/10.1134/S0006297907130032.
31. Nigg EA. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386:779-787.
32. Pante N, Kann M. 2002. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell 13:425-434. http://dx.doi.org/10.1091/mbc.01-06-0308.
33. Moore MS, Blobel G. 1993. The GTP-binding protein Ran/TC4 is required for protein import into the nucleus. Nature 365:661-663.
34. Melchior F, Paschal B, Evans J, Gerace L. 1993. Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J. Cell Biol. 123:1649-1659.
35. Rexach M, Blobel G. 1995. Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 83:683-692.
36. Gorlich D, Pante N, Kutay U, Aebi U, BischoffFR. 1996. Identification of different roles for RanGDP and RanGTP in nuclear protein import. EMBO J. 15:5584-5594.
37. Cohen S, Au S, Pante N. 2011. How viruses access the nucleus. Biochim. Biophys. Acta 1813:1634-1645. http://dx.doi.org/10.1016/j.bbamcr.2010.12.009.
38. Kobiler O, Drayman N, Butin-Israeli V, Oppenheim A. 2012. Virus strategies for passing the nuclear envelope barrier. Nucleus 3:526-539. http://dx.doi.org/10.4161/nucl.21979.
39. Wodrich H, Cassany A, D'Angelo MA, Guan T, Nemerow G, Gerace L. 2006. Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J. Virol. 80:9608-9618. http://dx.doi.org/10.1128/JVI.00850-06.
40. Sodeik B, Ebersold MW, Helenius A. 1997. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136:1007-1021.
41. Ojala PM, Sodeik B, Ebersold MW, Kutay U, Helenius A. 2000. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol. 20: 4922-4931. http://dx.doi.org/10.1128/MCB.20.13.4922-4931.2000.
42. Kann M, Sodeik B, Vlachou A, Gerlich WH, Helenius A. 1999. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:45-55.
43. Yeh CT, Liaw YF, Ou JH. 1990. The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport. J. Virol. 64:6141-6147.
44. Eckhardt SG, Milich DR, McLachlan A. 1991. Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. J. Virol. 65:575-582.
45. Cohen S, Behzad AR, Carroll JB, Pante N. 2006. Parvoviral nuclear import: bypassing the host nuclear-transport machinery. J. Gen. Virol. 87:3209-3213. http://dx.doi.org/10.1099/vir.0.82232-0.
46. Cohen S, Marr AK, Garcin P, Pante N. 2011. Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle. J. Virol. 85:4863-4874. http://dx.doi.org/10.1128/JVI.01999-10.
47. Hoque M, Ishizu K, Matsumoto A, Han SI, Arisaka F, Takayama M, Suzuki K, Kato K, Kanda T, Watanabe H, Handa H. 1999. Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation. J. Virol. 73:7912-7915.
48. Xiao W, Warrington KH, Jr, Hearing P, Hughes J, Muzyczka N. 2002. Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J. Virol. 76:11505-11517. http://dx.doi.org/10.1128/JVI.76.22.11505-11517.2002.
49. Popa-Wagner R, Porwal M, Kann M, Reuss M, Weimer M, Florin L, Kleinschmidt JA. 2012. Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry. J. Virol. 86:9163-9174. http://dx.doi.org/10.1128/JVI.00282-12.
50. Porwal M, Cohen S, Snoussi K, Popa-Wagner R, Anderson F, Dugot-Senant N, Wodrich H, Dinsart C, Kleinschmidt JA, Pante N, Kann M. 2013. Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis. PLoS Pathog. 9(10):e1003671. http://dx.doi.org/10.1371/journal.ppat.1003671.
51. Grieger JC, Choi VW, Samulski RJ. 2006. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1:1412-1428. http://dx.doi.org/10.1038/nprot.2006.207.
52. Gray SJ, Choi VW, Asokan A, Haberman RA, McCown TJ, Samulski RJ. 2011. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Curr. Protoc. Neurosci. Chapter 4:Unit 4.17. http://dx.doi.org/10.1002/0471142301.ns0417s57.
53. Zhong L, Li B, Jayandharan G, Mah CS, Govindasamy L, Agbandje-McKenna M, Herzog RW, Weigel-Van Aken KA, Hobbs JA, Zolotukhin S, Muzyczka N, Srivastava A. 2008. Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology 381:194-202. http://dx.doi.org/10.1016/j.virol.2008.08.027.
54. Zhong L, Zhao W, Wu J, Li B, Zolotukhin S, Govindasamy L, Agbandje-McKenna M, Srivastava A. 2007. A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis. Mol. Ther. 15:1323-1330. http://dx.doi.org/10.1038/sj.mt.6300170.
55. Finlay DR, Newmeyer DD, Price TM, Forbes DJ. 1987. Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J. Cell Biol. 104:189-200.
56. Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M. 1998. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273:13347-13352.
57. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. 1995. Nuclear import of influenza virusRNAcan be mediated by viral nucleoprotein and transport factors required for protein import. J. Biol. Chem. 270:22701-22704.
58. Warrington KH, Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. 2004. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J. Virol. 78:6595-6609. http://dx.doi.org/10.1128/JVI.78.12.6595-6609.2004.
59. Fried H, Kutay U. 2003. Nucleocytoplasmic transport: taking an inventory. Cell. Mol. Life Sci. 60:1659-1688. http://dx.doi.org/10.1007/s00018-003-3070-3.
60. Macara IG. 2001. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:570-594. http://dx.doi.org/10.1128/MMBR.65.4.570-594.2001.
61. Gorlich D, Dabrowski M, BischoffFR, Kutay U, Bork P, Hartmann E, Prehn S, Izaurralde E. 1997. A novel class of RanGTP binding proteins. J. Cell Biol. 138:65-80.
62. Jakel S, Albig W, Kutay U, BischoffFR, Schwamborn K, Doenecke D, Gorlich D. 1999. The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J. 18:2411-2423.
63. Rebane A, Aab A, Steitz JA. 2004. Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. RNA 10:590-599. http://dx.doi.org/10.1261/rna.5224304.
64. Kohler M, Ansieau S, Prehn S, Leutz A, Haller H, Hartmann E. 1997. Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett. 417: 104-108.
65. Malik HS, Eickbush TH, Goldfarb DS. 1997. Evolutionary specialization of the nuclear targeting apparatus. Proc. Natl. Acad. Sci. U. S. A. 94: 13738-13742.
66. Muhlhausser P, Muller EC, Otto A, Kutay U. 2001. Multiple pathways contribute to nuclear import of core histones. EMBO Rep. 2:690-696. http://dx.doi.org/10.1093/embo-reports/kve168.
67. Mosammaparast N, Jackson KR, Guo Y, Brame CJ, Shabanowitz J, Hunt DF, Pemberton LF. 2001. Nuclear import of histone H2A and H2B is mediated by a network of karyopherins. J. Cell Biol. 153:251-262. http://dx.doi.org/10.1083/jcb.153.2.251.
68. Copeland AM, Newcomb WW, Brown JC. 2009. Herpes simplex virus replication: roles of viral proteins and nucleoporins in capsid-nucleus attachment. J. Virol. 83:1660-1668. http://dx.doi.org/10.1128/JVI.01139-08.
69. Wisnivesky JP, Leopold PL, Crystal RG. 1999. Specific binding of the adenovirus capsid to the nuclear envelope. Hum. Gene Ther. 10:2187-2195.
70. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, Helenius A. 1997. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16:5998-6007.
71. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF. 2001. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3:1092-1100. http://dx.doi.org/10.1038/ncb1201-1092.
72. Yamada M, Kasamatsu H. 1993. Role of nuclear pore complex in simian virus 40 nuclear targeting. J. Virol. 67:119-130.
73. Yoneda Y, Imamoto-Sonobe N, Yamaizumi M, Uchida T. 1987. Reversible inhibition of protein import into the nucleus by wheat germ agglutinin injected into cultured cells. Exp. Cell Res. 173:586-595.
74. Ros C, Kempf C. 2004. The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice. Virology 324: 350-360. http://dx.doi.org/10.1016/j.virol.2004.04.016.
75. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. 2000. Endosomal processing limits gene transfer to polarized airway epithelia by adenoassociated virus. J. Clin. Invest. 105:1573-1587. http://dx.doi.org/10.1172/JCI8317.
76. Salganik M, Venkatakrishnan B, Bennett A, Lins B, Yarbrough J, Muzyczka N, Agbandje-McKenna M, McKenna R. 2012. Evidence for pH-dependent protease activity in the adeno-associated virus capsid. J. Virol. 86:11877-11885. http://dx.doi.org/10.1128/JVI.01717-12.
77. Sarma A, Yang W. 2011. Calcium regulation of nucleocytoplasmic transport. Protein Cell 2:291-302. http://dx.doi.org/10.1007/s13238-011-1038-x.
78. 2+ stores in intact mammalian cells. J. Gen. Physiol. 113:239-248.
79. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
80. Gallay P, Hope T, Chin D, Trono D. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. U. S. A. 94:9825-9830.
81. Vodicka MA, Koepp DM, Silver PA, Emerman M. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-185.
82. Wang P, Palese P, O'Neill RE. 1997. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71:1850-1856.
83. O'Neill RE, Palese P. 1995. NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology 206:116-125.
84. Melen K, Fagerlund R, Franke J, Kohler M, Kinnunen L, Julkunen I. 2003. Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J. Biol. Chem. 278:28193-28200. http://dx.doi.org/10.1074/jbc. M303571200.
85. Kelley JB, Talley AM, Spencer A, Gioeli D, Paschal BM. 2010. Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors. BMC Cell Biol. 11:63. http://dx.doi.org/10.1186/1471-2121-11-63.
86. Kohler M, Speck C, Christiansen M, BischoffFR, Prehn S, Haller H, Gorlich D, Hartmann E. 1999. Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol. Cell. Biol. 19:7782-7791.
87. Grieger JC, Johnson JS, Gurda-Whitaker B, Agbandje-McKenna M, Samulski RJ. 2007. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. J. Virol. 81:7833-7843. http://dx.doi.org/10.1128/JVI.00580-07.
88. Riddick G, Macara IG. 2007. The adapter importin-alpha provides flexible control of nuclear import at the expense of efficiency. Mol. Syst. Biol. 3:118. http://dx.doi.org/10.1038/msb4100160.
89. Keiser NW, Yan Z, Zhang Y, Lei-Butters DC, Engelhardt JF. 2011. Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells. Hum. Gene Ther. 22:1433-1444. http://dx.doi.org/10.1089/hum.2011.044.
90. Bevington JM, Needham PG, Verrill KC, Collaco RF, Basrur V, Trempe JP. 2007. Adeno-associated virus interactions with B23/nucleophosmin: identification of sub-nucleolar virion regions. Virology 357:102-113. http://dx.doi.org/10.1016/j.virol.2006.07.050.
91. Qiu J, Brown KE. 1999. A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology 257:373-382.